Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: Population-based cohort study

Home Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: Population-based cohort study

Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: Population-based cohort study

Apr 22, 2022 | Posted by ICAMH.org@gmail.com |

Although concerns continue regarding the neurobiological implications of stimulant treatment for children with ADHD, this study shows how children who receive earlier stimulant treatment during childhood have lower overall mortality than those who have delated use of this medication.

Chen, V., Chan, H., Wu, S., Lu, M., Dewey, M., Stewart, R., & Lee, C. (2022). Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: Population-based cohort study. The British Journal of Psychiatry, 220(2), 64-72. doi:10.1192/bjp.2020.129

https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/abs/methylphenidate-and-mortality-in-children-with-attentiondeficit-hyperactivity-disorder-populationbased-cohort-study/6E6BB02E78B00903D1F2D93D586CBB8B

Back

Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: Population-based cohort study

Methylphenidate and mortality in children with attention-deficit hyperactivity disorder: Population-based cohort study

Find us on